Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Platelet Glycoprotein GPIIb-IIIa Complex | 11 | 2014 | 61 | 2.540 |
Why?
|
| Blood Platelets | 17 | 2020 | 326 | 1.990 |
Why?
|
| Integrin beta3 | 7 | 2012 | 27 | 1.430 |
Why?
|
| Fibrinogen | 13 | 2014 | 152 | 1.240 |
Why?
|
| Proline | 5 | 2006 | 72 | 0.980 |
Why?
|
| Protein Phosphatase 1 | 5 | 2013 | 49 | 0.940 |
Why?
|
| Platelet Aggregation | 9 | 2014 | 120 | 0.940 |
Why?
|
| Platelet Activation | 3 | 2020 | 70 | 0.910 |
Why?
|
| Cell Adhesion | 8 | 2014 | 321 | 0.800 |
Why?
|
| Protein Phosphatase 2 | 4 | 2013 | 29 | 0.790 |
Why?
|
| Signal Transduction | 10 | 2014 | 4511 | 0.790 |
Why?
|
| Phosphoprotein Phosphatases | 3 | 2013 | 114 | 0.710 |
Why?
|
| Thrombosis | 6 | 2020 | 515 | 0.570 |
Why?
|
| Calcineurin | 2 | 2014 | 100 | 0.540 |
Why?
|
| RNA Interference | 2 | 2015 | 496 | 0.520 |
Why?
|
| Protein Isoforms | 7 | 2014 | 408 | 0.510 |
Why?
|
| Thrombin | 3 | 2013 | 60 | 0.500 |
Why?
|
| von Willebrand Factor | 5 | 2014 | 198 | 0.500 |
Why?
|
| Diacylglycerol Kinase | 1 | 2015 | 15 | 0.490 |
Why?
|
| Complement Activation | 1 | 2015 | 50 | 0.480 |
Why?
|
| Integrin alpha2 | 2 | 2012 | 9 | 0.450 |
Why?
|
| Polymorphism, Genetic | 5 | 2006 | 805 | 0.450 |
Why?
|
| Catalytic Domain | 2 | 2014 | 154 | 0.440 |
Why?
|
| Membrane Microdomains | 1 | 2013 | 60 | 0.430 |
Why?
|
| Endothelial Cells | 1 | 2015 | 527 | 0.370 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2010 | 7 | 0.360 |
Why?
|
| src-Family Kinases | 1 | 2010 | 83 | 0.350 |
Why?
|
| Phosphorylation | 8 | 2014 | 1613 | 0.330 |
Why?
|
| Calcineurin Inhibitors | 1 | 2009 | 28 | 0.320 |
Why?
|
| Flow Cytometry | 6 | 2014 | 810 | 0.310 |
Why?
|
| Platelet Membrane Glycoprotein IIb | 2 | 2006 | 7 | 0.310 |
Why?
|
| Granulocytes | 3 | 1997 | 65 | 0.290 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 3 | 2005 | 111 | 0.280 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2006 | 31 | 0.270 |
Why?
|
| Prothrombin | 1 | 2006 | 24 | 0.270 |
Why?
|
| Neoplasms | 1 | 2020 | 2753 | 0.260 |
Why?
|
| Endothelium, Vascular | 1 | 2009 | 514 | 0.260 |
Why?
|
| Gene Expression Regulation | 2 | 2013 | 2534 | 0.260 |
Why?
|
| Platelet Adhesiveness | 3 | 2014 | 40 | 0.250 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 1997 | 99 | 0.250 |
Why?
|
| Protein Binding | 6 | 2014 | 1732 | 0.230 |
Why?
|
| Enzyme Activation | 5 | 2012 | 621 | 0.220 |
Why?
|
| HEK293 Cells | 3 | 2014 | 741 | 0.210 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 2002 | 66 | 0.210 |
Why?
|
| Cell-Derived Microparticles | 2 | 2014 | 31 | 0.210 |
Why?
|
| Fibronectins | 3 | 2003 | 104 | 0.200 |
Why?
|
| Animals | 18 | 2015 | 33721 | 0.200 |
Why?
|
| Antigens, Human Platelet | 2 | 2008 | 6 | 0.200 |
Why?
|
| Cell Line | 7 | 2010 | 2782 | 0.190 |
Why?
|
| CHO Cells | 6 | 2008 | 158 | 0.190 |
Why?
|
| Cricetinae | 6 | 2008 | 403 | 0.190 |
Why?
|
| Humans | 30 | 2020 | 122296 | 0.180 |
Why?
|
| Mice | 9 | 2014 | 17546 | 0.170 |
Why?
|
| Protein Kinase C | 2 | 2011 | 151 | 0.170 |
Why?
|
| Clot Retraction | 2 | 2012 | 6 | 0.150 |
Why?
|
| Immunoblotting | 2 | 2010 | 312 | 0.140 |
Why?
|
| RNA, Small Interfering | 2 | 2010 | 663 | 0.140 |
Why?
|
| P-Selectin | 1 | 1997 | 77 | 0.140 |
Why?
|
| Transfection | 3 | 2012 | 1076 | 0.140 |
Why?
|
| Coronary Disease | 1 | 2000 | 634 | 0.130 |
Why?
|
| Stress, Mechanical | 3 | 2014 | 171 | 0.130 |
Why?
|
| Serum Albumin, Bovine | 1 | 1995 | 48 | 0.120 |
Why?
|
| Collagen | 2 | 2013 | 311 | 0.120 |
Why?
|
| Indicators and Reagents | 1 | 1995 | 51 | 0.120 |
Why?
|
| Myosin Light Chains | 2 | 2005 | 14 | 0.120 |
Why?
|
| Microtubules | 1 | 2015 | 195 | 0.120 |
Why?
|
| Risk Factors | 4 | 2020 | 9902 | 0.120 |
Why?
|
| Ferric Compounds | 1 | 2014 | 37 | 0.120 |
Why?
|
| Time Factors | 3 | 2014 | 6182 | 0.120 |
Why?
|
| Chlorides | 1 | 2014 | 104 | 0.120 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 2 | 2014 | 41 | 0.120 |
Why?
|
| Shear Strength | 1 | 2014 | 17 | 0.120 |
Why?
|
| Megakaryocytes | 2 | 2008 | 48 | 0.120 |
Why?
|
| Cryoelectron Microscopy | 1 | 2015 | 212 | 0.120 |
Why?
|
| Enzyme Inhibitors | 2 | 2009 | 582 | 0.110 |
Why?
|
| Vimentin | 1 | 2014 | 65 | 0.110 |
Why?
|
| Carotid Arteries | 1 | 2014 | 151 | 0.110 |
Why?
|
| Inflammation | 1 | 2020 | 1392 | 0.110 |
Why?
|
| Vasculitis | 1 | 2012 | 49 | 0.100 |
Why?
|
| Cells, Cultured | 2 | 2009 | 3074 | 0.100 |
Why?
|
| Protein Interaction Mapping | 1 | 2012 | 85 | 0.100 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2012 | 132 | 0.100 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2012 | 137 | 0.100 |
Why?
|
| Ovarian Neoplasms | 1 | 2015 | 413 | 0.100 |
Why?
|
| Risk Assessment | 1 | 2020 | 3307 | 0.100 |
Why?
|
| Phenotype | 2 | 2014 | 4151 | 0.090 |
Why?
|
| Isoenzymes | 2 | 2009 | 222 | 0.090 |
Why?
|
| Blood Preservation | 1 | 2011 | 30 | 0.090 |
Why?
|
| Mitochondria | 1 | 2015 | 666 | 0.090 |
Why?
|
| STAT3 Transcription Factor | 1 | 2012 | 217 | 0.090 |
Why?
|
| Cryopreservation | 1 | 2011 | 82 | 0.090 |
Why?
|
| Plasma | 1 | 2011 | 96 | 0.090 |
Why?
|
| Mice, Inbred BALB C | 2 | 2011 | 979 | 0.090 |
Why?
|
| Receptors, Thrombin | 1 | 2009 | 11 | 0.090 |
Why?
|
| Lipids | 1 | 2013 | 512 | 0.090 |
Why?
|
| Secretory Vesicles | 1 | 2009 | 19 | 0.090 |
Why?
|
| Phosphoserine | 1 | 2009 | 41 | 0.090 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 197 | 0.090 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2009 | 58 | 0.090 |
Why?
|
| Peptides | 1 | 2013 | 798 | 0.090 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2009 | 65 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2008 | 207 | 0.080 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2009 | 18 | 0.080 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 2441 | 0.080 |
Why?
|
| Antibodies | 1 | 2010 | 371 | 0.080 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2012 | 525 | 0.080 |
Why?
|
| Carrier Proteins | 1 | 2013 | 1015 | 0.080 |
Why?
|
| Biomarkers, Tumor | 1 | 2015 | 1424 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 1296 | 0.070 |
Why?
|
| DNA Primers | 1 | 2009 | 668 | 0.070 |
Why?
|
| Protein Phosphatase 2C | 1 | 2008 | 55 | 0.070 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2005 | 312 | 0.070 |
Why?
|
| Pyrimidines | 1 | 2010 | 375 | 0.070 |
Why?
|
| Glutathione | 1 | 2008 | 197 | 0.070 |
Why?
|
| Heart Transplantation | 1 | 2014 | 853 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 493 | 0.070 |
Why?
|
| Receptors, Estrogen | 2 | 2001 | 788 | 0.070 |
Why?
|
| Cell Movement | 2 | 2002 | 838 | 0.070 |
Why?
|
| Cytoskeleton | 2 | 2014 | 178 | 0.070 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 2 | 2003 | 88 | 0.070 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2012 | 213 | 0.060 |
Why?
|
| Myosin-Light-Chain Phosphatase | 1 | 2005 | 5 | 0.060 |
Why?
|
| Cricetulus | 2 | 2008 | 99 | 0.060 |
Why?
|
| Densitometry | 1 | 2005 | 24 | 0.060 |
Why?
|
| Threonine | 1 | 2005 | 60 | 0.060 |
Why?
|
| Heart-Assist Devices | 1 | 2014 | 1022 | 0.060 |
Why?
|
| Tyrosine | 1 | 2005 | 167 | 0.060 |
Why?
|
| Base Sequence | 1 | 2009 | 3109 | 0.060 |
Why?
|
| Leucine | 1 | 2005 | 309 | 0.060 |
Why?
|
| Conserved Sequence | 1 | 2004 | 291 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 2009 | 2826 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2003 | 461 | 0.050 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2002 | 148 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 3 | 2001 | 1076 | 0.050 |
Why?
|
| Binding Sites | 1 | 2004 | 1292 | 0.050 |
Why?
|
| Heart Failure | 1 | 2014 | 2125 | 0.050 |
Why?
|
| Cytochalasin D | 1 | 2000 | 12 | 0.040 |
Why?
|
| Biopolymers | 1 | 2000 | 21 | 0.040 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2000 | 22 | 0.040 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2000 | 24 | 0.040 |
Why?
|
| Cell Size | 1 | 2000 | 81 | 0.040 |
Why?
|
| Models, Biological | 1 | 2005 | 1438 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2004 | 2674 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 4282 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 1 | 2000 | 223 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2000 | 387 | 0.040 |
Why?
|
| Point Mutation | 1 | 2000 | 346 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2000 | 356 | 0.040 |
Why?
|
| Actins | 1 | 2000 | 339 | 0.040 |
Why?
|
| Receptors, Androgen | 1 | 2000 | 408 | 0.030 |
Why?
|
| Neuraminidase | 1 | 1997 | 34 | 0.030 |
Why?
|
| Female | 4 | 2015 | 64883 | 0.030 |
Why?
|
| Testosterone | 1 | 2000 | 459 | 0.030 |
Why?
|
| Alleles | 1 | 2000 | 1579 | 0.030 |
Why?
|
| Toll-Like Receptors | 1 | 2015 | 83 | 0.030 |
Why?
|
| Chemokines | 1 | 2015 | 136 | 0.030 |
Why?
|
| Hot Temperature | 1 | 1995 | 135 | 0.030 |
Why?
|
| Male | 3 | 2014 | 59522 | 0.030 |
Why?
|
| Bleeding Time | 1 | 2014 | 8 | 0.030 |
Why?
|
| Leukocytes | 1 | 2015 | 204 | 0.030 |
Why?
|
| Cattle | 1 | 1995 | 555 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 1995 | 230 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 1994 | 968 | 0.030 |
Why?
|
| Syk Kinase | 1 | 2012 | 12 | 0.030 |
Why?
|
| Phospholipase C gamma | 1 | 2012 | 17 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2012 | 3770 | 0.030 |
Why?
|
| Kidney | 1 | 2000 | 1340 | 0.030 |
Why?
|
| Cell Survival | 1 | 1995 | 816 | 0.030 |
Why?
|
| Partial Thromboplastin Time | 1 | 2011 | 46 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2014 | 758 | 0.020 |
Why?
|
| Oligopeptides | 1 | 2011 | 119 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2012 | 394 | 0.020 |
Why?
|
| Hemostasis | 1 | 2011 | 67 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 1997 | 1022 | 0.020 |
Why?
|
| Thrombelastography | 1 | 2011 | 55 | 0.020 |
Why?
|
| Solutions | 1 | 2010 | 65 | 0.020 |
Why?
|
| Estrogen Receptor beta | 2 | 2001 | 78 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1679 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 546 | 0.020 |
Why?
|
| Protein Stability | 1 | 2010 | 166 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2014 | 1362 | 0.020 |
Why?
|
| Cytokines | 1 | 2015 | 1272 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2000 | 3050 | 0.020 |
Why?
|
| Purinergic P2 Receptor Agonists | 1 | 2009 | 2 | 0.020 |
Why?
|
| Purinergic P2 Receptor Antagonists | 1 | 2009 | 5 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 2010 | 235 | 0.020 |
Why?
|
| Receptors, Purinergic P2Y1 | 1 | 2009 | 12 | 0.020 |
Why?
|
| Thromboxanes | 1 | 2009 | 10 | 0.020 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2009 | 20 | 0.020 |
Why?
|
| Adenosine Diphosphate | 1 | 2009 | 58 | 0.020 |
Why?
|
| Glutathione Disulfide | 1 | 2008 | 20 | 0.020 |
Why?
|
| Adenosine Monophosphate | 1 | 2009 | 43 | 0.020 |
Why?
|
| Peptides, Cyclic | 1 | 2009 | 53 | 0.020 |
Why?
|
| Hemorheology | 1 | 2008 | 28 | 0.020 |
Why?
|
| Pulsatile Flow | 1 | 2008 | 133 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 751 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2008 | 445 | 0.020 |
Why?
|
| Atherosclerosis | 1 | 2012 | 828 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 5013 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 4366 | 0.010 |
Why?
|
| Vitronectin | 1 | 2002 | 4 | 0.010 |
Why?
|
| Diffusion Chambers, Culture | 1 | 2002 | 6 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2014 | 5963 | 0.010 |
Why?
|
| Isoantigens | 1 | 2002 | 18 | 0.010 |
Why?
|
| Sialoglycoproteins | 1 | 2002 | 48 | 0.010 |
Why?
|
| Osteopontin | 1 | 2002 | 49 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2002 | 94 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2002 | 158 | 0.010 |
Why?
|
| Glycosylation | 1 | 2001 | 110 | 0.010 |
Why?
|
| Antigens, CD34 | 1 | 2000 | 107 | 0.010 |
Why?
|
| RNA Splicing | 1 | 2001 | 223 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2000 | 330 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2000 | 1104 | 0.010 |
Why?
|
| Middle Aged | 2 | 2011 | 25640 | 0.010 |
Why?
|
| Young Adult | 1 | 2011 | 8760 | 0.010 |
Why?
|
| Mutation | 1 | 2010 | 5734 | 0.010 |
Why?
|
| Adult | 2 | 2011 | 28733 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2000 | 541 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2001 | 741 | 0.010 |
Why?
|
| Aged | 1 | 2011 | 18785 | 0.010 |
Why?
|
| Adolescent | 1 | 2011 | 18940 | 0.010 |
Why?
|